CompletedNot applicableNCT04687007
SMART-ALD - A New Lifestyle Intervention to Improve Quality of Life in Women With X-linked Adrenoleukodystrophy (X-ALD)
Studying X-linked adrenoleukodystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Leipzig University Medical Center
- Principal Investigator
- Wolfgang Köhler, MDLeipzig University Medical Center, Leukodystrophy Outpatient Clinic, Department of Neurology, Leipzig, Germany
- Intervention
- SMART-ALD(behavioral)
- Enrollment
- 68 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2022 – 2024
Study locations (2)
- Leipzig University Medical Center, Leukodystrophy Outpatient Clinic, Department of Neurology, Leipzig, Germany, Leipzig, Saxony, Germany
- Leukodystrophy Outpatient Clinic, Leipzig, Germany
Collaborators
European Leukodystrophy Association
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04687007 on ClinicalTrials.govOther trials for X-linked adrenoleukodystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT03727555IT and IV Lentiviral Gene Therapy for X-ALDShenzhen Geno-Immune Medical Institute
- RECRUITINGNCT06178120Disease Progression in Women With X-linked AdrenoleukodystrophyMinoryx Therapeutics, S.L.
- RECRUITINGNCT05939232Registry of X-linked AdrenoleukodystrophyBeijing Tiantan Hospital
- RECRUITINGNCT04675749Quality of Life in Women with X-linked AdrenoleukodystrophyLeipzig University Medical Center